1. Home
  2. VIR vs ARRY Comparison

VIR vs ARRY Comparison

Compare VIR & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • ARRY
  • Stock Information
  • Founded
  • VIR 2016
  • ARRY 1989
  • Country
  • VIR United States
  • ARRY United States
  • Employees
  • VIR N/A
  • ARRY N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • ARRY Semiconductors
  • Sector
  • VIR Health Care
  • ARRY Technology
  • Exchange
  • VIR Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • VIR 1.0B
  • ARRY 998.2M
  • IPO Year
  • VIR 2019
  • ARRY 2020
  • Fundamental
  • Price
  • VIR $9.60
  • ARRY $6.04
  • Analyst Decision
  • VIR Buy
  • ARRY Buy
  • Analyst Count
  • VIR 5
  • ARRY 23
  • Target Price
  • VIR $36.40
  • ARRY $13.08
  • AVG Volume (30 Days)
  • VIR 1.3M
  • ARRY 8.1M
  • Earning Date
  • VIR 10-31-2024
  • ARRY 11-07-2024
  • Dividend Yield
  • VIR N/A
  • ARRY N/A
  • EPS Growth
  • VIR N/A
  • ARRY N/A
  • EPS
  • VIR N/A
  • ARRY N/A
  • Revenue
  • VIR $78,618,000.00
  • ARRY $982,190,000.00
  • Revenue This Year
  • VIR N/A
  • ARRY N/A
  • Revenue Next Year
  • VIR N/A
  • ARRY $28.63
  • P/E Ratio
  • VIR N/A
  • ARRY N/A
  • Revenue Growth
  • VIR N/A
  • ARRY N/A
  • 52 Week Low
  • VIR $7.12
  • ARRY $5.56
  • 52 Week High
  • VIR $13.09
  • ARRY $20.15
  • Technical
  • Relative Strength Index (RSI)
  • VIR 68.12
  • ARRY 43.63
  • Support Level
  • VIR $7.12
  • ARRY $5.91
  • Resistance Level
  • VIR $10.44
  • ARRY $7.73
  • Average True Range (ATR)
  • VIR 0.54
  • ARRY 0.48
  • MACD
  • VIR 0.25
  • ARRY -0.04
  • Stochastic Oscillator
  • VIR 74.70
  • ARRY 9.63

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: